Jane Street Group, LLC Enochian Biosciences Inc Transaction History

Jane Street Group, LLC

  • $481 Billion
  • Q2 2025

A detailed history of Jane Street Group, LLC transactions in Enochian Biosciences Inc stock. As of the latest transaction made, Jane Street Group, LLC holds 893,046 shares of ENOB stock, worth $4.11 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
893,046
Holding current value
$4.11 Million
% of portfolio
0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 14, 2025
BUY
N/A
893,046 New
893,046 $4.11 Million
Q4 2024

Feb 14, 2025
SELL
N/A
-10,541 Reduced 50.53%
10,321 $47,000
Q3 2024

Nov 14, 2024
SELL
N/A
-14,956 Reduced 41.76%
20,862 $95,000
Q2 2024

Aug 14, 2024
SELL
N/A
-98,021 Reduced 73.24%
35,818 $164,000
Q1 2024

May 15, 2024
BUY
N/A
77,107 Added 135.91%
133,839 $615,000
Q4 2023

Feb 14, 2024
BUY
$4.3 - $4.7 $243,947 - $266,640
56,732 New
56,732 $260,000
Q2 2023

Aug 14, 2023
BUY
$0.4 - $1.3 $33,251 - $108,066
83,128 New
83,128 $47,000
Q2 2022

Aug 16, 2022
SELL
$1.93 - $8.73 $82,136 - $371,531
-42,558 Closed
0 $0
Q1 2022

May 17, 2022
BUY
$4.42 - $9.0 $105,067 - $213,939
23,771 Added 126.53%
42,558 $351,000
Q4 2021

Feb 15, 2022
BUY
$6.71 - $12.55 $126,060 - $235,776
18,787 New
18,787 $137,000
Q3 2021

Nov 16, 2021
SELL
$4.56 - $7.88 $54,482 - $94,150
-11,948 Closed
0 $0
Q2 2021

Aug 16, 2021
BUY
$2.94 - $6.79 $35,127 - $81,126
11,948 New
11,948 $59,000
Q3 2020

Nov 17, 2020
SELL
$3.42 - $4.55 $43,228 - $57,512
-12,640 Closed
0 $0
Q2 2020

Aug 17, 2020
BUY
$2.78 - $6.06 $35,139 - $76,598
12,640 New
12,640 $53,000

Others Institutions Holding ENOB

# of Institutions
44
Shares Held
14.8M
Call Options Held
107K
Put Options Held
0
View Full List

About Enochian Biosciences Inc

ENOB Quotes by TradingView
  • Ticker ENOB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 52,950,000
  • Market Cap $244M
  • Description
  • Enochian Biosciences, Inc., a pre-clinical stage biotechnology company, engages in the research and development of pharmaceutical and biological products for the human treatment of human immunodeficiency virus (HIV), hepatitis B virus (HBV), influenza and coronavirus infections, and cancer. The company's lead candidate includes ENOB-HV-01 for au...
More about ENOB
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email